Goldman Sachs’s abrdn Healthcare Investors HQH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-12,517
| Closed | -$237K | – | 6708 |
|
|
2025
Q4 | $237K | Hold |
12,517
| – | – | ﹤0.01% | 5973 |
|
|
2025
Q3 | $231K | Buy |
12,517
+377
| +3% | +$6.16K | ﹤0.01% | 5889 |
|
|
2025
Q2 | $188K | Buy |
12,140
+408
| +3% | +$6.32K | ﹤0.01% | 5684 |
|
|
2025
Q1 | $191K | Buy |
11,732
+788
| +7% | +$13.5K | ﹤0.01% | 5654 |
|
|
2024
Q4 | $176K | Buy |
10,944
+8
| +0.1% | +$142 | ﹤0.01% | 5677 |
|
|
2024
Q3 | $204K | Sell |
10,936
-70,209
| -87% | -$1.31M | ﹤0.01% | 5448 |
|
|
2024
Q2 | $1.42M | Buy |
+81,145
| New | +$1.36M | ﹤0.01% | 4204 |
|
|
2020
Q2 | – | Sell |
-55,591
| Closed | -$990K | – | 5323 |
|
|
2020
Q1 | $990K | Buy |
+55,591
| New | +$1.1M | ﹤0.01% | 3769 |
|
|
2018
Q2 | – | Sell |
-37,402
| Closed | -$805K | – | 5810 |
|
|
2018
Q1 | $805K | Sell |
37,402
-58,417
| -61% | -$1.34M | ﹤0.01% | 4185 |
|
|
2017
Q4 | $2.16M | Buy |
95,819
+55,968
| +140% | +$1.31M | ﹤0.01% | 3736 |
|
|
2017
Q3 | $1M | Sell |
39,851
-43,479
| -52% | -$1.09M | ﹤0.01% | 4565 |
|
|
2017
Q2 | $2.09M | Buy |
83,330
+66,364
| +391% | +$1.64M | ﹤0.01% | 3801 |
|
|
2017
Q1 | $408K | Sell |
16,966
-2,932
| -15% | -$68.8K | ﹤0.01% | 5208 |
|
|
2016
Q4 | $420K | Sell |
19,898
-13,440
| -40% | -$299K | ﹤0.01% | 5201 |
|
|
2016
Q3 | $794K | Sell |
33,338
-46,163
| -58% | -$1.16M | ﹤0.01% | 4621 |
|
|
2016
Q2 | $1.86M | Sell |
79,501
-182,575
| -70% | -$4.53M | ﹤0.01% | 3688 |
|
|
2016
Q1 | $6.29M | Sell |
262,076
-12,699
| -5% | -$302K | ﹤0.01% | 2566 |
|
|
2015
Q4 | $8.15M | Sell |
274,775
-142,458
| -34% | -$4.4M | ﹤0.01% | 2416 |
|
|
2015
Q3 | $11.5M | Sell |
417,233
-455,590
| -52% | -$15.5M | ﹤0.01% | 2141 |
|
|
2015
Q2 | $30.3M | Sell |
872,823
-122,983
| -12% | -$4.27M | 0.01% | 1492 |
|
|
2015
Q1 | $33.9M | Buy |
995,806
+76,764
| +8% | +$2.58M | 0.01% | 1383 |
|
|
2014
Q4 | $28.3M | Sell |
919,042
-265,320
| -22% | -$7.97M | 0.01% | 1564 |
|
|
2014
Q3 | $32.9M | Sell |
1,184,362
-905,071
| -43% | -$24.5M | 0.01% | 1407 |
|
|
2014
Q2 | $53.9M | Buy |
2,089,433
+1,807,783
| +642% | +$47.1M | 0.02% | 1039 |
|
|
2014
Q1 | $7.5M | Buy |
281,650
+29,392
| +12% | +$817K | ﹤0.01% | 2620 |
|
|
2013
Q4 | $6.65M | Sell |
252,258
-16,531
| -6% | -$405K | ﹤0.01% | 2764 |
|
|
2013
Q3 | $6.3M | Sell |
268,789
-16,787
| -6% | -$397K | ﹤0.01% | 2699 |
|
|
2013
Q2 | $6.42M | Buy |
+285,576
| New | +$6.07M | ﹤0.01% | 2495 |
|
Other funds holding HQH
PCM
AAM
NIM
ZCP
Goldman Sachs's HQH Position: Q1 2026 in Review
Goldman Sachs sold out of abrdn Healthcare Investors (HQH) in Q1 2026, closing a stake of 12,517 shares — an estimated $237K sold.
Goldman Sachs first reported a position in HQH in Q2 2013 and held it in 28 quarters. The position peaked at $53.9M in Q2 2014. 128 funds tracked by Wall St. Rank hold HQH as of Q1 2026.
- Goldman Sachs reported no remaining abrdn Healthcare Investors position as of Q1 2026 after selling out during the quarter.
- Goldman Sachs sold 12,517 abrdn Healthcare Investors shares in Q1 2026, an estimated $237K.
- Goldman Sachs first reported a position in abrdn Healthcare Investors in Q2 2013 and held it in 28 quarters.
- Goldman Sachs's abrdn Healthcare Investors position peaked at $53.9M in Q2 2014.
- 128 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.